Media Room
Fourth Quarter & Full Year 2025 Results
Fourth quarter and full year 2025 results will be reviewed by management during a live audio webcast with the financial community on January 29, 2026. The presentation will be followed by a Q&A session.
Press Releases
January 23, 2026
Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis
January 12, 2026
Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
July 2025
Half-year Financial Reports
Half Year 2025 Financial Report
July 2025
Half-year Financial Reports
Half year 2025 financial report XBRL package
September 2024
Annual Report on Form 20-F
Annual Report on Form 20-F 2024
July 2024
Half-year Financial Reports
Half Year 2024 Financial Report